The overlap of functional dyspepsia and irritable bowel syndrome: a random combination or appropriate relationship?

Aim. Assessment of the quality of life and physical activity level in students with and without symptoms of functional dyspepsia (FD) and irritable bowel syndrome (IBS) according to questionnaire “7×7” (7 symptoms per 7 days).Materials and methods. Symptoms of FD and IBS were surveyed using the “7×7” questionnaire. Level of physical activity was evaluated according to the short IPAQ, and quality of life — to WAM questionnaires.Results. The study surveyed 92 students aged 20.7 ± 0.2 years (56 men and 36 women). We report borderline manifestations of functional disorders of the gastrointestinal tract (GIT) in 51.1 %, and FD and/or IBS symptoms of mild to moderate severity in 23.9 % of respondents. Symptoms of FD and/or IBS were equally common in men and women. Severity of FD and/or IBS symptoms was rated 4 [[3; 7] in men and 4 [[4; 11] in women (p = 0.25). Physical activity of 57.6 % in students corresponded to a moderate level. Healthy students were more likely to exhibit higher physical activity than individuals with FD and/or IBS symptoms, 56.5 and 31.9 %, respectively (p = 0.04). The level of wellbeing and severity of FD and/or IBS symptoms correlated negatively (r = –0.28, p = 0.01). Wellbeing and mood correlated directly with physical activity, r = 0.33, p = 0.001 and r = 0.27, respectively (p = 0.01).Conclusions. 1. Symptoms of FD and/or IBS occur widely among students and equally in men and women. Functional disorders of the gastrointestinal tract of mild to moderate severity occur in 23.9 % of students, with borderline symptoms registered with every second individual. 2. Healthy students significantly more often exhibited higher physical activity compared to individuals with FD and/or IBS symptoms of varying severity in the ratios of 56.5 and 31.9 % (p = 0.04). 3. Severity of FD and/or IBS in students negatively correlates with the wellbeing component of quality of life (r = –0.28, p = 0.01).

Download Full-text

Probiotics and Prebiotics in the Treatment of Irrıtable Bowel Syndrome and Functional Dyspepsia

Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Dergisi ◽

10.21020/husbfd.437227 ◽

2019 ◽

Author(s):

Gözde Ağca ◽

Ece Yalçın ◽

Zeynep Göktaş

Keyword(s):

Irritable Bowel Syndrome ◽

Functional Dyspepsia ◽

Irritable Bowel

Download Full-text

Does the Prevalence of Fructose and Lactose Intolerance Differ Between ROME III Subgroups of Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS)?

Gastroenterology ◽

10.1016/s0016-5085(11)60097-8 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-25

Author(s):

Clive H. Wilder-Smith ◽

Andrea Materna

Keyword(s):

Irritable Bowel Syndrome ◽

Functional Dyspepsia ◽

Lactose Intolerance ◽

Rome Iii ◽

Irritable Bowel

Download Full-text

Combined detection of inorganic syndromes of the gastrointestinal tract and their differential diagnosis.

Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini ◽

10.15407/internalmed2021.02.068 ◽

2021 ◽

Vol 2021 (2) ◽

pp. 68-71

Author(s):

R.I. Khalafova ◽

Keyword(s):

Irritable Bowel Syndrome ◽

Differential Diagnosis ◽

Gastrointestinal Tract ◽

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Functional Dyspepsia ◽

Military Personnel ◽

Reflux Disease ◽

Irritable Bowel ◽

Combined Detection

To study the frequency of detection of combinations of the main syndromes of the gastrointestinal tract (GIT) and their differential diagnosis, consisting of irritable bowel syndrome (IBS), syndrome of functional dyspepsia (SFD), chronic idiopathic dyspepsia (CIT) and gastroesophageal reflux disease (GERD). The main gastrointestinal syndromes are quite often detected among different groups of military personnel and members of their families. ES plays an important role in their formation. International recommendations allow anamnestic diagnosis of each of the syndromes in separately and in combination with each other. The medical appealability of patients depends on the severity of the symptoms of the syndromes, it is most pronounced when they are combined.

Download Full-text

Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders

Frontiers in Pharmacology ◽

10.3389/fphar.2020.596467 ◽

2020 ◽

Vol 11 ◽

Author(s):

Chloé Melchior ◽

Charlotte Desprez ◽

Fabien Wuestenberghs ◽

Anne-Marie Leroi ◽

Antoine Lemaire ◽

...

Keyword(s):

Quality Of Life ◽

Irritable Bowel Syndrome ◽

Functional Dyspepsia ◽

Functional Gastrointestinal Disorders ◽

Opioid Consumption ◽

University Hospital ◽

Gastrointestinal Disorders ◽

Gi Symptoms ◽

Irritable Bowel

Objective: We aimed to determine the burden of opioid consumption in a cohort of patients with functional gastrointestinal disorders.Methods: All patients diagnosed with functional gastrointestinal disorders and referred to our university hospital were evaluated from 2013 to the beginning of 2019. Irritable bowel syndrome and functional dyspepsia diagnoses were determined according to Rome criteria and severity according to irritable bowel syndrome severity scoring system. Vomiting was quantified using a 5-point Likert scale, and constipation severity was measured using the Knowles-Eccersley-Scott-Symptom questionnaires. Quality of life was quantified by the GastroIntestinal Quality of Life Index. Patients were categorized as being treated on a chronic basis with either tramadol, step II opioids, step III opioids or as being opioid-free.Results: 2933 consecutive patients were included. In our cohort, 12.5% had only irritable bowel syndrome, 39.3% had only functional dyspepsia, 24.9% had a combination of both, and 23.4% had other functional gastrointestinal disorders. Among them, the consumption of tramadol, step II (tramadol excluded) and step III opioids was 1.8, 1.3 and 0.3 % respectively in 2013 and 4.3, 3.4 and 1.9% in 2018 (p < 0.03). Opioid consumption was associated with increased vomiting (p = 0.0168), constipation (p < 0.0001), symptom severity (p < 0.001), more altered quality of life (p < 0.0001) and higher depression score (p = 0.0045).Conclusion: In functional gastrointestinal disorders, opioid consumption has increased in the last years and is associated with more GI symptoms (vomiting, constipation and GI severity), higher depression and more altered quality of life.

Download Full-text